T1	Participants 723 796	patients at least 55 years old with vascular disease or diabetes mellitus
T2	Participants 1129 1211	3994 continued to take the study intervention, and 738 agreed to passive follow-up
T3	Participants 2301 2370	patients enrolled at the centers participating in the HOPE-TOO trial,
T4	Participants 2554 2605	patients with vascular disease or diabetes mellitus
